Back to Results
First PageMeta Content
Medicinal chemistry / Pharmacometrics / Food and Drug Administration / Topotecan / Pharmacology / Pharmaceutical sciences / Clinical research


Clinical Pharmacology and Biopharmaceutics Executive Summary NDA 20,671/SE8 010
Add to Reading List

Document Date: 2004-06-08 09:30:54

Open Document

File Size: 83,85 KB

Share Result on Facebook

City

Collegeville / /

Company

GlaxoSmithKline / D. Submission Type NDA-Supplement I. / /

Event

FDA Phase / /

MedicalCondition

leukemia / refractory solid tumors / tumor / solid tumors / leukemias / /

Organization

FDA / /

Person

Carl-Michael Staschen / N.A.M. Atiqur Rahman / Pharmacometrics Reviewer Carl-Michael / Anne Zajicek / Joga Gobburu / /

Position

Team Leader / Executive / Ph. Executive / /

Product

Hycamtin / SE8 / /

ProvinceOrState

Pennsylvania / /

SocialTag